Whole blood lead levels are associated with biomarkers of joint tissue metabolism in African American and white men and women: The Johnston County Osteoarthritis Project

Environmental Research

Volumn 111, Issue 8, 2011, Pages 1208-1214

  Nelson, Amanda E ^a   Chaudhary, Sanjay ^a   Kraus, Virginia B ^b   Fang, Fang ^c   Chen, Jiu Chiuan ^d   Schwartz, Todd A ^a,e   Shi, Xiaoyan A ^f   Renner, Jordan B ^a   Stabler, Thomas V ^b   Helmick, Charles G ^g   Caldwell, Kathleen ^g   Robin Poole, A ^h,i   Jordan, Joanne M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c StatWorks Inc   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e IL   (United States)

^f SAS INSTITUTE INC   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^h SHRINERS HOSPITAL FOR CHILDREN   (Canada)

ⁱ MCGILL UNIVERSITY   (Canada)

Author keywords

Biomarkers; Blood lead; Joints; Osteoarthritis

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; CARTILAGE OLIGOMERIC MATRIX PROTEIN; HYALURONIC ACID; LEAD; PROCOLLAGEN;

BIOCHEMICAL COMPOSITION; BIOMARKER; BODY MASS; CALCIFICATION; DEVELOPMENTAL BIOLOGY; LEAD; LINEARITY; MATHEMATICAL ANALYSIS; METABOLISM; NUMERICAL MODEL; ORGANIC ACID; PATHOLOGY; PEPTIDE; PROTEIN; REGRESSION ANALYSIS; SERUM;

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; BODY MASS; BONE TURNOVER; CAUCASIAN; FEMALE; GENDER; HUMAN; LEAD BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; TISSUE METABOLISM;

AFRICAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LEAD; MALE; MIDDLE AGED; OSTEOARTHRITIS;

UNITED STATES;

EID: 81155161917     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2011.08.002     Document Type: Article

References (61)

1. Barbosa F., Tanus-Santos J.E., Gerlach R.F., Parsons P.J. A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs. Environ. Health Perspect 2005, 113:1669-1674.
2. Barry P.S., Mossman D.B. Lead concentrations in human tissues. Br. J. Ind. Med. 1970, 27:339-351.
3. Bay-Jensen A.C., Andersen T.L., Charni-Ben T.N., Kristensen P.W., Kjaersgaard-Andersen P., Sandell L., Garnero P., Delaisse J.M. Biochemical markers of type II collagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilage. Osteoarthritis Cartilage 2008, 16:615-623.
4. Berlin K., Gerhardsson L., Borjesson J., Lindh E., Lundstrom N., Schutz A., Skerfving S., Edling C. Lead intoxication caused by skeletal disease. Scand. J. Work Environ. Health 1995, 21:296-300.
5. Bettica P., Cline G., Hart D.J., Meyer J., Spector T.D. Evidence for increased bone resorption in patients with progressive knee osteoarthritis-longitudinal results from the Chingford study. Arthritis Rheum. 2002, 46:3178-3184.
6. Cahue S., Sharma L., Dunlop D., Ionescu M., Song J., Lobanok T., King L., Poole A.R. The ratio of type II collagen breakdown to synthesis and its relationship with the progression of knee osteoarthritis. Osteoarthritis Cartilage 2007, 15:819-823.
7. Carmouche J.J., Puzas J.E., Zhang X.P., Tiyapatanaputi P., Cory-Slechta D.A., Gelein R., Zuscik M., Rosier R.N., Boyce B.F., O'Keefe R.J., Schwarz E.M. Lead exposure inhibits fracture healing and is associated with increased chondrogenesis, delay in cartilage mineralization, and a decrease in osteoprogenitor frequency. Environ. Health Perspect 2005, 113:749-755.
8. Centers for Disease Control and Prevention (CDC), 2009. Adult Blood Lead Epidemiology and Surveillance-United States, 2005-2007. MMWR Morbidity and Mortality Weekly Report, vol. 58, pp. 365-369.
9. Christgau S., Garnero P., Fledelius C., Moniz C., Ensig M., Gineyts E., Rosenquist C., Qvist P. Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone 2001, 29:209-215.
10. Chu Q., Lopez M., Hayashi K., Ionescu M., Billinghurst R.C., Johnson K.A., Poole A.R., Markel M.D. Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog. Osteoarthritis Cartilage 2002, 10:662-669.
11. Cibere J., Zhang H., Garnero P., Poole A.R., Lobanok T., Saxne T., Kraus V.B., Way A., Thorne A., Wong H., Singer J., Kopec J., Guermazi A., Peterfy C., Nicolaou S., Munk P.L., Esdaile J.M. Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study. Arthritis Rheum. 2009, 60:1372-1380.
12. Clark A.G., Jordan J.M., Vilim V., Renner J.B., Dragomir A.D., Luta G., Kraus VB. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project. Arthritis Rheum. 1999, 42:2356-2364.
13. Dowd T.L., Rosen J.F., Mints L., Gundberg C.M. The effect of Pb(2+) on the structure and hydroxyapatite binding properties of osteocalcin. Biochim. Biophys. Acta 2001, 1535:153-163.
14. Elliot A., Kraus V.B., Luta G., Stabler T., Renner J.B., Woodard J., Dragomir A., Helmick C., Hochberg M., Jordan J.M. Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African-Americans and Caucasians in the Johnston County Osteoarthritis Project. Arthritis Rheum. 2005, 52:105-111.
15. Fullmer CS. Lead-calcim interactions: involvement of 1,25-dihydroxyvitamin D. Environ. Res. 1997, 72:45-55.
16. Garnero P., Rousseau J., Delmas P.D. Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases. Arthritis Rheum. 2000, 43:953.
17. Georges C., Vigneron H., Ayral X., Listrat V., Ravaud P., Dougados M., Sharif M., Dieppe P., Saxne T. Serum biologic markers as predictors of disease progression in osteoarthritis of the knee. Arthritis Rheum. 1997, 40:590-591.
18. Goldberg R.L., Kaplan S.R., Fuller G.C. Effect of heavy metals on human rheumatoid synovial cell proliferation and collagen synthesis. Biochem. Pharmacol. 1983, 32:2763-2766.
19. Jain N.B., Potula V., Schwartz J., Vokonas P.S., Sparrow D., Wright R.O., Nie H., Hu H. Lead levels and ischemic heart disease in a prospective study of middle-aged and elderly men: the VA Normative aging study. Environ. Health Perspect 2007, 115:871-875.
20. Jordan J.M., Helmick C.G., Renner J.B., Luta G., Dragomir A.D., Woodard J., Fang F., Schwartz T.A., Abbate L.M., Callahan L.F., Kalsbeek W.D., Hochberg M.C. Prevalence of knee symptoms and radiographic and symptomatic knee osteoarthritis in African Americans and Caucasians: the Johnston County Osteoarthritis Project. J. Rheumatol. 2007, 34:172-180.
21. Jordan J.M., Luta G., Stabler T., Renner J.B., Dragomir A.D., Vilim V., Hochberg M.C., Helmick C.G., Kraus V.B. Ethnic and sex differences in serum levels of cartilage oligomeric matrix protein: the Johnston County Osteoarthritis Project. Arthritis Rheum. 2003, 48:675-681.
22. Khalil N., Wilson J.W., Talbott E.O., Morrow L.A., Hochberg M.C., Hillier T.A., Muldoon S.B., Cummings S.R., Cauley J.A. Association of blood lead concentrations with mortality in older women: a prospective cohort study. Environ. Health 2009, 8:15.
23. Kojima T., Kojima M., Noda K., Ishiguro N., Poole A.R. Influences of menopause, aging, and gender on the cleavage of type II collagen in cartilage in relationship to bone turnover. Menopause 2008, 15:133-137.
24. Kong S.Y., Stabler T.V., Criscione L.G., Elliott A.L., Jordan J.M., Kraus V.B. Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis. Arthritis Rheum. 2006, 54:2496-2504.
25. Kraus, V.B., Kepler, T.B., Stabler, T.V., Renner, J.B., Atif, U., Jordan, J.M., 2010. First qualification study of serum biomarkers as indicators of total body burden of osteoarthritis. PLoS ONE 5 (3), e9739. http://doi:10.1371/journal.pone.0009739.
26. Kumm J., Tamm A., Veske K., Lintrop M., Tamm A. Associations between cartilage oligomeric matrix protein and several articular tissues in early knee joint osteoarthritis. Rheumatology (Oxford) 2006, 45:1308-1309.
27. Kutner M., Nachtsheim C., Neter J, Li W. Applied Linear Statistical Models 2004, McGraw-Hill/Irwin.
28. Machida M., Sun S.J., Oguma E., Kayama F. High bone matrix turnover predicts blood levels of lead among perimenopausal women. Environ. Res. 2009, 109:880-886.
29. Martin D., Glass T.A., Bandeen-Roche K., Todd A.C., Shi W., Schwartz B.S. Association of blood lead and tibia lead with blood pressure and hypertension in a community sample of older adults. Am. J. Epidemiol. 2006, 163:467-478.
30. Matyas J.R., Atley L., Ionescu M., Eyre D.R., Poole A.R. Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis. Arthritis Rheum. 2004, 50:543-552.
31. Mazzuca S.A., Poole A.R., Brandt K.D., Katz B.P., Lane K.A., Lobanok T. Associations between joint space narrowing and molecular markers of collagen and proteoglycan turnover in patients with knee osteoarthritis. J. Rheumatol. 2006, 33:1147-1151.
32. Meulenbelt I., Kloppenburg M., Kroon H.M., Houwing-Duistermaat J.J., Garnero P., Hellio le Graverand M.P., DeGroot J., Slagboom P.E. Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study. Ann. Rheum. Dis. 2006, 65:360-365.
33. Mouritzen U., Christgau S., Lehmann H.J., Tanko L.B., Christiansen C. Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: influence of age, sex, menopause, hormone replacement therapy, and body mass index. Ann. Rheum. Dis. 2003, 62:332-336.
34. Muntner P., Menke A., DeSalvo K.B., Rabito F.A., Batuman V. Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys. Arch. Intern. Med. 2005, 165:2155-2161.
35. Mushak P. New directions in the toxicokinetics of human lead exposure. Neurotoxicology 1993, 14:29-42.
36. Nash D., Magder L.S., Sherwin R., Rubin R.J., Silbergeld E.K. Bone density-related predictors of blood lead level among peri- and postmenopausal women in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am. J. Epidemiol. 2004, 160:901-911.
37. Nelson A.E., Shi X.A., Schwartz T.A., Chen J.C., Renner J.B., Caldwell K.L., Helmick C.G., Jordan J.M. Whole blood lead levels are associated with radiographic and symptomatic knee osteoarthritis: a cross-sectional analysis in the Johnston County Osteoarthritis Project. Arthritis Res. Ther. 2011, 13:R37.
38. Nelson F., Dahlberg L., Laverty S., Reiner A., Pidoux I., Ionescu M., Fraser G.L., Brooks E., Tanzer M., Rosenberg L.C., Dieppe P., Poole A.R. Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J. Clin. Invest. 1998, 102:2115-2125.
39. Nie H., Sanchez B.N., Wilker E., Weisskopf M.G., Schwartz J., Sparrow D., Hu H. Bone lead and endogenous exposure in an environmentally exposed elderly population: the normative aging study. J. Occup. Environ. Med. 2009, 51:848-857.
40. Osterloh J.D., Kosnett M.J., Becker C.E., Osterloh J., Kelly T.J., Pasta D.J. Factors influencing bone lead concentration in a suburban community assessed by noninvasixe K X-ray fluorescence. J. Am. Med. Assoc. 1994, 271:197-203.
41. Petersson I.F., Boegard T., Svensson B., Heinegard D., Saxne T. Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint. Br. J. Rheumatol. 1998, 37:46-50.
42. Potula V., Henderson A., Kaye W. Calcitropic hormones, bone turnover, and lead exposure among female smelter workers. Arch. Environ. Occup. Health 2005, 60:195-204.
43. Pounds J.G., Long G.J., Rosen J.F. Cellular and molecular toxicity of lead in bone. (Review) (144 Refs.). Environ. Health Perspect 1991, 91:17-32.
44. Reijman M., Hazes J.M.W., Bierma-Zeinstra S.M.A., Koes B.W., Christgau S., Christiansen C., Uitterlinden A.G., Pols H.A.P. A new marker for osteoarthritis-cross-sectional and longitudinal approach. Arthritis Rheum. 2004, 50:2471-2478.
45. Sakai T. Biomarkers of lead exposure. (Review) (141 Refs.). Ind. Health 2000, 38:127-142.
46. Scariano J.K., Glew R.H., Bou-Serhal C.E., Clemens J.D., Garry P.J., Baumgartner R.N. Serum levels of cross-linked N-telopeptides and aminoterminal propeptides of type I collagen indicate low bone mineral density in elderly women. Bone 1998, 23:471-477.
47. Schober S.E., Mirel L.B., Graubard B.I., Brody D.J., Flegal K.M. Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III mortality study. Environ. Health Perspect 2006, 114:1538-1541.
48. Sharif M., George E., Shepstone L., Knudson W., Thonar M.A., Thonar E.J., Cushnaghan J., Dieppe P. Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum. 1995, 38:760-767.
49. Sharif M., Saxne T., Shepstone L., Kirwan J.R., Elson C.J., Heinegard D., Dieppe P.A. Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint. Br. J. Rheumatol. 1995, 34:306-310.
50. Staessen J.A., Lauwerys R.R., Buchet J., Bulpitt C.J., Rondia D., Vanrenterghem Y., Amery A. Impairment of renal function with increasing blood lead concentrations in the general population. N. Engl. J. Med. 1992, 327:151-156.
51. Subramanian K.S. Storage and preservation of blood and urine for trace element analysis. a review. Biol. Trace Elem. Res. 1995, 49:187-210.
52. Symanski E., Hertz-Picciotto I. Blood lead levels in relation to menopause, smoking, and pregnancy history. Am. J. Epidemiol. 1995, 141:1047-1058.
53. Tomiya M., Fujikawa K., Ichimura S., Kikuchi T., Yoshihara Y., Nemoto K. Skeletal unloading induces a full-thickness patellar cartilage defect with increase of urinary collagen II CTx degradation marker in growing rats. Bone 2008, 44:295-305.
54. Tsaih S.W., Korrick S., Schwartz J., Lee M.L., Amarasiriwardena C., Aro A., Sparrow D., Hu H. Influence of bone resorption on the mobilization of lead from bone among middle-aged and elderly men: the Normative Aging Study. Environ. Health Perspect 2001, 109:995-999.
55. Vilim V., Voburka Z., Vytasek R., Senolt L., Tchetverikov I., Kraus V.B., Pavelka K. Monoclonal antibodies to human cartilage oligomeric matrix protein (COMP): epitope mapping and characterization of sandwich ELISA. Clin. Chim. Acta 2002, 328:59-69.
56. Wang S.T., Peter F. The stability of human blood lead in storage. J. Anal. Toxicol. 1985, 9:85-88.
57. Weisskopf M.G., Jain N., Nie H., Sparrow D., Vokonas P., Schwartz J., Hu H. A prospective study of bone lead concentration and death from all causes, cardiovascular diseases, and cancer in the Department of Veterans Affairs Normative Aging Study. Circulation 2009, 120:1056-1064.
58. Wells A.F., Klareskog L., Lindblad S., Laurent T.C. Correlation between increased hyaluronan localized in arthritic synovium and the presence of proliferating cells: a role for macrophage-derived factors. Arthritis Rheum. 1992, 35:391-396.
59. Wittmers L.E., Aufderheide A.C., Wallgren J., Rapp G., Alich A. Lead in bone. IV. Distribution of lead in the human skeleton. Arch. Environ. Health 1988, 43:381-391.
60. Zoeger N., Roschger P., Hofstaetter J.G., Jokubonis C., Pepponi G., Falkenberg G., Fratzl P., Berzlanovich A., Osterode W., Streli C., Wobrauschek P. Lead accumulation in tidemark of articular cartilage. Osteoarthritis Cartilage 2006, 14:906-913.
61. Zuscik M.J., Puzas E., O'Keefe R.J., Sheu T., Holz J.D., Rosier R.N., Ubayawardena R. Pb exposure regulates a complex interplay of signaling pathways in articular chondrocytes that ultimately leads to phenotypic changes resembling osteoarthritis. The Toxicologist CD-An Official Journal of the Society of Toxicology 2006, 90(S-1).